AI companies have been testing and using synthetic data (at least) since we a) realised that labels are expensive in supervised deep learning and b) started seriously looking at AI on sensitive data.
@nathanbenaich
-
Airstreet Building Foundation Model for Venture Capital
By
–
@airstreet is building the foundation model for VC.
-
AI State Overview: History, Compute, Open Source and Safety
By
–
Last month I had the pleasure to deliver a (very abridged) @stateofaireport talk to open @sanalabs AI Summit in Stockholm.
— Nathan Benaich (@nathanbenaich) 19 juillet 2023
I cover some brief AI history, compute, open source, safety, bio, fusion, et al.
The 10 minute talk is now up and I hope you enjoy it! pic.twitter.com/pnx4AOTUirLast month I had the pleasure to deliver a (very abridged) @stateofai talk to open @sanalabs AI Summit in Stockholm. I cover some brief AI history, compute, open source, safety, bio, fusion, et al. The 10 minute talk is now up and I hope you enjoy it!
-
Orca: Progressive Learning from GPT-4 Explanation Traces
By
–
https://
microsoft.com/en-us/research
/publication/orca-progressive-learning-from-complex-explanation-traces-of-gpt-4/
… -
Step-by-Step Reasoning Improves AI Learning Like Human Cognition
By
–
Eerie and logical that step-by-step reasoning is a better way to teach AI systems given that’s how we humans learn complex tasks. “Our research indicates that learning from step-by-step explanations, whether these are generated by humans or more advanced AI models, is a
-
Allcyte Pioneer Approach Validated Across AI Industry
By
–
Yeah, team Allcyte (acq. EXAI) were pioneers here. Several are following because this approach makes pragmatic sense. And we have evidence it works 🙂
-
Exscientia Launches Ovarian Cancer Observational Study
By
–
https://
s28.q4cdn.com/460399462/file
s/doc_news/Exscientia-Initiates-Prospective-Observational-Study-in-Ovarian-Cancer-2023.pdf
… -
AI-Powered Drug Response Testing Transforms Cancer Treatment Selection
By
–
If I told you that cancer drugs weren't selected on the basis of how a patient's biopsied cancer cells reacted to said drugs, wouldn't you say that was nuts? Today, @exscientiaAI announced the initiation of EXCYTE-1 to study the relationship between ex vivo drug response in
-
AI-First Protein Design: ProfluentBio Leads Innovation
By
–
AI-first protein design is one to watch. @ProfluentBio is the one to watch.
-
Tractable AI Raises $65M Led by SoftBank Investment Round
By
–
https://
businessinsider.com/tractable-ai-s
tartup-raises-65-million-in-round-led-by-softbank-2023-7
…